NVCR Stock Skyrockets After Novocure Pulls Off A Once-In-Six-Years Feat
Adding Novocure's (NVCR) medical device to standard drugs improved survival for late-stage lung cancer patients, leading NVCR stock to skyrocket Thursday.
X
The company sells a device that uses electrical fields at specific…